239 related articles for article (PubMed ID: 34776454)
1. Circulatory GSK-3β: Blood-Based Biomarker and Therapeutic Target for Alzheimer's Disease.
Kumari S; Singh A; Singh AK; Yadav Y; Bajpai S; Kumar P; Upadhyay AD; Shekhar S; Dwivedi S; Dey AB; Dey S
J Alzheimers Dis; 2022; 85(1):249-260. PubMed ID: 34776454
[TBL] [Abstract][Full Text] [Related]
2. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
3. The protective underlying mechanisms of Schisandrin on SH-SY5Y cell model of Alzheimer's disease.
Zhao ZY; Zhang YQ; Zhang YH; Wei XZ; Wang H; Zhang M; Yang ZJ; Zhang CH
J Toxicol Environ Health A; 2019; 82(19):1019-1026. PubMed ID: 31739764
[TBL] [Abstract][Full Text] [Related]
4. Tannoid principles of Emblica officinalis attenuated aluminum chloride induced apoptosis by suppressing oxidative stress and tau pathology via Akt/GSK-3βsignaling pathway.
Justin Thenmozhi A; Dhivyabharathi M; Manivasagam T; Essa MM
J Ethnopharmacol; 2016 Dec; 194():20-29. PubMed ID: 27566203
[TBL] [Abstract][Full Text] [Related]
5. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
Wu X; Kosaraju J; Tam KY
Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
[TBL] [Abstract][Full Text] [Related]
6. Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease.
Sharma N; Tramutola A; Lanzillotta C; Arena A; Blarzino C; Cassano T; Butterfield DA; Di Domenico F; Perluigi M; Barone E
Neurobiol Dis; 2019 May; 125():176-189. PubMed ID: 30738142
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease.
Liu W; Liu X; Tian L; Gao Y; Liu W; Chen H; Jiang X; Xu Z; Ding H; Zhao Q
Eur J Med Chem; 2021 Oct; 222():113554. PubMed ID: 34098466
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
[TBL] [Abstract][Full Text] [Related]
9. Ginkgo biloba Extract EGb761 Attenuates Hyperhomocysteinemia-induced AD Like Tau Hyperphosphorylation and Cognitive Impairment in Rats.
Zeng K; Li M; Hu J; Mahaman YAR; Bao J; Huang F; Xia Y; Liu X; Wang Q; Wang JZ; Yang Y; Liu R; Wang X
Curr Alzheimer Res; 2018; 15(1):89-99. PubMed ID: 28847282
[TBL] [Abstract][Full Text] [Related]
10. Mori Fructus improves cognitive and neuronal dysfunction induced by beta-amyloid toxicity through the GSK-3β pathway in vitro and in vivo.
Kim HG; Park G; Lim S; Park H; Choi JG; Jeong HU; Kang MS; Lee MK; Oh MS
J Ethnopharmacol; 2015 Aug; 171():196-204. PubMed ID: 26068423
[TBL] [Abstract][Full Text] [Related]
11. RNA Interference Silencing of Glycogen Synthase Kinase 3β Inhibites Tau Phosphorylation in Mice with Alzheimer Disease.
Bian H; Bian W; Lin X; Ma Z; Chen W; Pu Y
Neurochem Res; 2016 Sep; 41(9):2470-80. PubMed ID: 27255602
[TBL] [Abstract][Full Text] [Related]
12. Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer's pathologies?
Manoharan SD; Abdul Hamid H; Md Hashim NF; Cheema MS; Chiroma SM; Mustapha M; Mehat MZ
Brain Res; 2024 Apr; 1829():148793. PubMed ID: 38309553
[TBL] [Abstract][Full Text] [Related]
13. NPD1 Enhances Autophagy and Reduces Hyperphosphorylated Tau and Amyloid-β42 by Inhibiting GSK3β Activation in N2a/APP695swe Cells.
Dai S; Zhou F; Sun J; Li Y
J Alzheimers Dis; 2021; 84(2):869-881. PubMed ID: 34602482
[TBL] [Abstract][Full Text] [Related]
14. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.
Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ
J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188
[TBL] [Abstract][Full Text] [Related]
15. Gypenoside IX restores Akt/GSK-3β pathway and alleviates Alzheimer's disease-like neuropathology and cognitive deficits.
Lei L; Luo Y; Kang D; Yang F; Meng D; Wang JZ; Liu R; Wang X; Li HL
Aging (Albany NY); 2023 Dec; 15(23):14172-14191. PubMed ID: 38095632
[TBL] [Abstract][Full Text] [Related]
16. MiR-539-5p Decreases amyloid β-protein production, hyperphosphorylation of Tau and Memory Impairment by Regulating PI3K/Akt/GSK-3β Pathways in APP/PS1 Double Transgenic Mice.
Jiang Y; Zhang Y; Su L
Neurotox Res; 2020 Aug; 38(2):524-535. PubMed ID: 32415525
[TBL] [Abstract][Full Text] [Related]
17. Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice.
Tan X; Liang Z; Li Y; Zhi Y; Yi L; Bai S; Forest KH; Nichols RA; Dong Y; Li QX
Behav Brain Res; 2021 Feb; 398():112968. PubMed ID: 33069740
[TBL] [Abstract][Full Text] [Related]
18. A Unique GSK-3β inhibitor B10 Has a Direct Effect on Aβ, Targets Tau and Metal Dyshomeostasis, and Promotes Neuronal Neurite Outgrowth.
Shi XL; Yan N; Cui YJ; Liu ZP
Cells; 2020 Mar; 9(3):. PubMed ID: 32155989
[TBL] [Abstract][Full Text] [Related]
19. The seed of
Sun Y; Wu A; Li X; Qin D; Jin B; Liu J; Tang Y; Wu J; Yu C
Pharm Biol; 2020 Dec; 58(1):35-43. PubMed ID: 31881157
[No Abstract] [Full Text] [Related]
20. Discovery of novel quinolin-2-one derivatives as potential GSK-3β inhibitors for treatment of Alzheimer's disease: Pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation.
Abdo Moustafa E; Abdelrasheed Allam H; Fouad MA; El Kerdawy AM; Nasser Eid El-Sayed N; Wagner C; Abdel-Aziz HA; Abdel Fattah Ezzat M
Bioorg Chem; 2024 May; 146():107324. PubMed ID: 38569322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
